Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims database

Conclusions When compared with similar patients who initiated treatment with OMPM, onabotulinumtoxinA was associated with a significantly lower likelihood of headache-related ED visits and hospitalizations.

http://cep.sagepub.com/cgi/content/abstract/36/9/862?rss=1

Source: Cephalalgia - July 21, 2016 Category: Neurology Authors: Hepp, Z., Rosen, N. L., Gillard, P. G., Varon, S. F., Mathew, N., Dodick, D. W. Tags: Original Articles Source Type: research